603300.SS
603300.SS
CNE100001ZX2
ZHEJIANG HAIKONG NANKE HUATIE D
Loading chart...
Elevated Business & Solvency Risk

Caution: In addition to price volatility, there are balance sheet risks due to higher debt or weaker liquidity (Health Score: 45/100).

Volatility Risk

Transparent evaluation of price volatility (SRI), Beta, and historical drawdowns.

Volatility Risk Score
7/7 Very High
7 / 7 SRI Price Fluctuation & Beta

Very high volatility or fundamental risks. Significant loss potential; strictly for aggressive investors. Moves noticeably less than the broader market (0.5x).

Beta (Market Relation)
0.45x
Defensive
Volatility (5Y p.a.)
44.3% p.a.
5-Year Horizon
Max Drawdown (5Y)
-66.3%
5-Year Horizon
Sharpe Ratio
-0.09
Return / Risk
Speculative / High Risk: Score Basis:

Multi-Horizon Risk & Performance Matrix

Historical volatility, drawdowns, and risk-adjusted return across 1, 3, 5, and 10 years.

Volatility Expansion (3Y > 5Y) High Volatility
Timeframe
Volatility (p.a.)
Max Drawdown
Sharpe Ratio
Return (p.a.)
1 Year — — — -47.4%
3 Years 48.4% -66.3% -0.24 -9%
5 Years 44.3% -66.3% -0.09 -1.6%
10 Years 44.0% -82.7% -0.07 -0.4%

Automated Risk & Health Notes (Red Flags)

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Critical leverage: Debt-to-Equity is at 290%.
Strong cyclicality: The business model is sensitive to economic downturns.
Elevated Short-Term Volatility: 3Y volatility (48.4%) is noticeably higher than the 5Y average (44.3%).
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (44.3% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -82.7% in the extended horizon.
ende